NCT00369187 Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase Status COMPLETED Phase PHASE4
NCT00367211 Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. Status COMPLETED Phase PHASE3
NCT00365001 A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis. Status COMPLETED Phase PHASE1
NCT00361634 Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT00361335 A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy Status COMPLETED Phase PHASE3
NCT00357903 Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials Status COMPLETED Phase PHASE3
NCT00356590 Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012 Status COMPLETED Phase PHASE3
NCT00356473 Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00346294 An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00345748 A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate Status COMPLETED Phase PHASE2
NCT00334620 Effectiveness of Radon Spa Therapy in Multimodal Rehabilitative Treatment of Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT00327275 The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis Status COMPLETED Phase NA
NCT00326339 Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1) Status COMPLETED Phase PHASE2
NCT00321217 Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis Status UNKNOWN Phase N/A
NCT00319917 A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients Status COMPLETED Phase PHASE4
NCT00317538 Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept Status COMPLETED Phase PHASE3